HCRT and obesity disorder: Considering the important influence of orexin-A in the regulation of feeding behavior and that OX1R antagonists represent potential pharmacological tools to treat obesity and aberrant eating patterns [10,106,107,108], future investigations should elucidate if the NPS effect on food intake is, at least, partially mediated by neuronal changes in orexin transmission.